Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Theravance Inc and Theravance Biopharma Inc announce completion of separation of late-stage partnered respiratory assets from biopharmaceutical operations

Monday, 2 Jun 2014 08:05pm EDT 

Theravance Inc and Theravance Biopharma Inc:Say completion of separation of Theravance Biopharma Inc, research and development-based biopharmaceutical business, from Theravance Inc to form two, independent, publicly traded companies with differing business objectives and opportunities.Separation is achieved via a dividend distribution of Theravance Biopharma shares to Theravance stockholders. 

Company Quote

-0.01 -0.11%
25 Nov 2015